Form D · Other Technology
3Bar Biologics, Inc.
Columbus, OH · CIK 0001693990
Offering snapshot reported Nov 25, 2020 · SEC filing
- Reported sold
- $780K Offering amount: $1M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 19, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 25, 2020 | Initial | $780,000 | No comparison | 11 | SEC filing |
| Apr 17, 2017 | Amendment | $1,575,000 | $610,000vs Jan 17, 2017 | 12 | SEC filing |
| Jan 17, 2017 | Initial | $965,000 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-381540
Source: Form D, filed Nov 25, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rashmi Agnihotri | Director |
| David Bergeron | Director |
| Bruce Caldwell | Director, Executive |
| Richard Maksimoski | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
1275 Kinnear Road
Columbus, OH, 43212
Columbus, OH, 43212